Dow Up 0.07% Nasdaq Up 0.61%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
194.72 Up 1.95(1.01%) Nov 26, 4:00PM EST
|After Hours : 194.72 0.00 (0.00%) Nov 26, 4:33PM EST
Prev Close:192.77
Open:193.28
Bid:187.45 x 200
Ask:195.10 x 100
1y Target Est:207.20
Beta:1.4
Earnings Date:Jan 28 - Feb 2 (Est.)
Day's Range:191.52 - 194.99
52wk Range:120.14 - 197.64
Volume:704,468
Avg Vol (3m):1,119,350
Market Cap:38.61B
P/E (ttm):81.00
EPS (ttm):2.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNUp 1.01%38.61B
AMGNUp 1.53%125.30B
BAXDown 0.06%39.24B

Key Statistics

Forward P/E (1 yr):32.89
P/S (ttm):18.41
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.20
Quarterly EPS Est (Dec-14) :1.29
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):1.22

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback